VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • March 1st, 2017 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Keith Kennedy (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of February 15, 2017 (the “Effective Date”).
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 1st, 2017 • Veracyte, Inc. • Services-medical laboratories • New York
THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Agreement”) dated as of December 14, 2016 (the “Effective Date”) is entered into among Veracyte, Inc., a Delaware corporation (the “Borrower”), the Guarantors, the Lenders party hereto and VISIUM HEALTHCARE PARTNERS, LP, a Delaware limited partnership, as Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement (as defined below).
SECOND AMENDMENT TO LEASELease • March 1st, 2017 • Veracyte, Inc. • Services-medical laboratories
This Second Amendment to Lease (the "Second Amendment") is dated as of February 8, 2017, by and between CRP 6000 Shoreline, L.L.C., a Delaware limited liability company ("Landlord"), and Veracyte, Inc., a Delaware corporation ("Tenant"), with reference to the following recitals.
